Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism

BACKGROUND: TNF receptor family agonists and checkpoint blockade combination therapies lead to minimal tumor clearance of poorly immunogenic tumors. Therefore, a need to enhance the efficacy of this combination therapy arises. Antigen-presenting cells (APCs) present antigen to T cells and steer the...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Jaina M., Cui, Zhihua, Wen, Zhi-Fa, Dinh, Catherine T., Hu, Hong-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865022/
https://www.ncbi.nlm.nih.gov/pubmed/31747946
http://dx.doi.org/10.1186/s40425-019-0786-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865022/
https://www.ncbi.nlm.nih.gov/pubmed/31747946
http://dx.doi.org/10.1186/s40425-019-0786-7

Ejemplares similares